Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Visible Light Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114874139A details a green visible-light method for 1-benzyl-3,4-dihydroisoquinoline. Offers cost-effective, scalable pharma intermediate production.
Patent CN110540516B reveals a mild visible-light mediated synthesis for dihydronaphthalene derivatives, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN110305054B details a green FeBr3-catalyzed route for N-(1-phenyl-2-(phenylseleno)ethyl)aniline derivatives, offering cost reduction and scalable manufacturing.
Patent CN113651788B enables green visible light catalysis for chromones. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN114560832A reveals a green two-step route to dibenzofurans using visible light and palladium catalysis, offering cost-effective manufacturing solutions.
Patent CN112047839B reveals a visible-light driven method for high-purity 1-iodo-3-perfluoroalkyl alkenes. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN112028841A reveals a catalyst-free visible light method for high-yield quinoxalinone synthesis, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel patent CN113651788B enables efficient room temperature synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing globally.
Patent CN111777564B details a green aqueous photocatalytic method for quinazolinones using KI, offering cost-effective and scalable production for pharmaceutical intermediates.
Patent CN112142680B details a metal-free visible light method for 3-trifluoroalkylquinoxalinones, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN108586527B reveals a metal-free visible light method for aryl phosphonates. Discover cost reduction in pharmaceutical intermediates manufacturing and scalable green synthesis.
Novel visible-light mediated synthesis of 2-acyl-9H-pyrrolo[1,2-a]indoles from N-propargyl indoles. Offers mild conditions, high yield, and scalable routes for pharmaceutical intermediates.
Patent CN111039737B reveals a visible-light catalyzed route for sulfone intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN107337663A enables metal-free visible light synthesis of 3-thiospirotrienone. Offers green manufacturing, reduced purification costs, and scalable supply chain solutions for pharma intermediates.
Patent CN112939891A reveals a metal-free visible light protocol for biphenyl benzothiazole. This method offers significant cost reduction and simplified supply chains for pharmaceutical intermediates.
Patent CN117088826B enables visible light oxazole synthesis. Offers green chemistry benefits and supply chain stability for pharmaceutical intermediate manufacturing.
Patent CN112778191A details a green photocatalytic route for indole allyl alcohols, offering high yield and mild conditions for reliable pharmaceutical intermediate supply.
Discover the novel photocatalytic synthesis of heterocyclic cyclopropanes from patent CN112898202B. A mild, high-yield route for pharmaceutical intermediates manufacturing.
Patent CN114874139A details a green visible-light method for synthesizing 1-benzyl-3,4-dihydroisoquinolines, offering cost-effective routes for pharmaceutical intermediates.
Patent CN117126077B reveals a green visible-light iron catalyzed route for 4-arylbutyronitrile. Achieve 100% atom economy and cost reduction in fine chemical manufacturing.